Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats (Q48226383)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 1999

Language	Label	Description	Also known as
English	Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats	scientific article published in February 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10218865

Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10218865

1 reference

based on heuristic

inferred from title

1

object named as

Wlaź P

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

author name string

Ebert U

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10218865

Löscher W

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10218865

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10218865

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10218865

38

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10218865

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10218865

243-251

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10218865

Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

The effects of ifenprodil and eliprodil on voltage-dependent Ca2 channels and in gerbil global cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

The NMDA receptor antagonist eliprodil (SL 82.0715) blocks voltage-operated Ca2 channels in rat cultured cortical neurons

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Block of P-type Ca2 channels by the NMDA receptor antagonist eliprodil in acutely dissociated rat Purkinje cells

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Adenosine analogues. The temperature-dependence of the anticonvulsant effect and inhibition of 3H-D-aspartate release

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Anticonvulsant Activity of Two Orally Active Competitive N-Methyl-D-Aspartate Antagonists, CGP 37849 and CGP 39551, Against Sound-Induced Seizures in DBA/2 Mice and Photically Induced Myoclonus in Papio papio

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Blockade by ifenprodil of high voltage-activated Ca2 channels in rat and mouse cultured hippocampal pyramidal neurones: comparison with N-methyl-D-aspartate receptor antagonist actions

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systemic administration

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Anticonvulsant action of excitatory amino acid antagonists

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice.

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Development and pharmacological suppression of secondary afterdischarges in the hippocampus of amygdala-kindled rats

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Anticonvulsant effects by combined treatment with a glycineB receptor antagonist and a polyamine site antagonist in amygdala-kindled rats

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Glycine potentiates the NMDA response in cultured mouse brain neurons

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Molecular diversity of the NMDA receptor channel

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Over-additive protective effect of dizocilpine and NBQX against neuronal damage

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Responses to NMDA receptor antagonists altered by epileptogenesis

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Ifenprodil inhibition of the 5-hydroxytryptamine3 receptor.

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Antiepileptic action of excitatory amino acid antagonists in the photosensitive baboon, papio papio

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Structure and function of the NMDA receptor channel

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Neomycin is an agonist at a polyamine site on the N-methyl-D-aspartate receptor

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Modification of seizure activity by electrical stimulation. II. Motor seizure

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Synergism between the NMDA receptor antagonistic effects of ifenprodil and the glycine antagonist, 7-chlorokynurenate, in vivo.

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Modulation of the NMDA receptor by polyamines

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Weak anticonvulsant effects of two novel glycineB receptor antagonists in the amygdala-kindling model in rats

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(98)00184-1

7 January 2021

Identifiers

10.1016/S0028-3908(98)00184-1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10218865

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10218865

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48226383&oldid=2190995970"